• The Week That Wasn't in COVID-19: Stool Surveillance, Smoking, 11-Days Infectious

    1 month ago - By Medscape

    Three medical stories that we didn't cover, explained.
    Read more ...


  • AstraZeneca donates $1.1 million to AKF's COVID-19 emergency fund

    1 month ago - By Healio

    Pharmaceutical company AstraZeneca has donated $1.1 million to the American Kidney Fund's coronavirus emergency relief program, allowing for all patients currently on the waitlist to receive financial assistance.
    The program, launched in March to provide monetary grants to low-income patients on dialysis or those who have undergone kidney transplantation, saw its funds quickly depleted, causing numerous corporations to make donations. Despite this support, the AKF was unable to provide assistance to increasing numbers of applicants, with more than 9,000 individuals applying for emergency
    Read more ...


  • Top 5 psychiatry stories of May

    1 month ago - By Healio

    Healio Psychiatry has compiled a list of its top five most-viewed stories in May.
    A poll on COVID-19's impact on parental stress levels, research on the role of environmental factors in autism prevalence and a study of the link between autism and sleep onset problems during infancy were just some of the most-read stories on Healio Psychiatry for the month.
    Which story resonated with you most? Leave a comment or write to us on Twitter HealioPsych.
    Parents experiencing high stress levels related to COVID-19, poll shows
    Nearly half of parents of children aged younger than 18 years reported
    Read more ...


  • Q&A: Remdesivir a ‘go-to' COVID-19 treatment, but questions remain

    1 month ago - By Healio

    Last month, Anthony S. Fauci, MD, announced unpublished data from a phase 3 trial that showed remdesivir shortened the time to recovery for patients with COVID-19 from 15 days to 11 days.
    Fauci, the director of the National Institute of Allergy and Infectious Diseases, said he believed Gilead Science's investigational antiviral “will be the standard of care” for the new disease.
    Results from the Adaptive COVID-19 Treatment Trial were finally published recently in The New England Journal of Medicine, with the same conclusion: Among more than 1,000 patients hospitalized
    Read more ...


  • Study identifies cardiopulmonary contributors to death in COVID-19

    1 month ago - By Healio

    An autopsy study of African Americans who died from COVID-19 in New Orleans has revealed that certain pulmonary and cardiac pathology likely contributed to severe disease and death in this patient population.
    “We found that the small vessels and capillaries in the lungs were obstructed by blood clots and associated hemorrhage that significantly contributed to decompensation and death in these patients,” Richard Vander Heide, MD, PhD, professor and director of pathology research at Louisiana State University Health Sciences Center in New Orleans, said in a press release. “We
    Read more ...


  • Coronavirus updates LIVE: Global COVID-19 cases top 5.8 million as Australian death toll stands at 103

    1 month ago - By Sydney Morning Herald

    If you suspect you or a family member has coronavirus you should call your GP or ring the national Coronavirus Health Information Hotline on 1800 020 080.
    Read more ...


  • Confirmed ischemic stroke rates low in COVID-19

    1 month ago - By Healio

    Patients hospitalized with COVID-19 had low rates of ischemic stroke confirmed by imaging, according to a study published in Stroke.
    The study also found that most strokes in these patients were cryptogenic and were linked to increased mortality.
    “As centers develop protocols for the prompt triage and assessment of patients with COVID-19, the co-occurrence of stroke and COVID-19 should be considered when weighing these risks,” Shadi Yaghi, MD, FAHA, director of vascular neurology at NYU Langone Hospital-Brooklyn, director of clinical vascular neurology research at NYU Langone Health
    Read more ...


  • Prior chemotherapy linked to mortality risk among patients with thoracic cancers, COVID-19

    1 month ago - By Healio

    Prior use of chemotherapy appeared associated with an increased risk for death among patients with lung or other thoracic cancers and COVID-19, according to study results presented during the ASCO20 Virtual Scientific Program.
    Patients with these malignancies who received anticoagulants and corticosteroids prior to COVID-19 diagnosis also had a higher risk for mortality, researchers noted.
    “The initial publications on COVID-19 in the general population suggested a higher mortality rate among patients with cancer,” Leora Horn, MD, MSc, Ingram associate professor of cancer research,
    Read more ...


  • Weekly Link Love - Edition 83

    Weekly Link Love - Edition 83

    1 month ago - By Mark's Daily Apple

    Research of the Week
    Diabetic patients taking metformin had lower coronavirus mortality than diabetic patients not taking it.
    “ Increased cardiovascular disease in African-Americans with Covid-19 .”
    Unsaturated fat intake and deficiencies in calcium and albumin linked to higher coronavirus mortality.
    “ Financial relationships between the leaders of influential US professional medical associations and industry are extensive ...”
    New Primal Blueprint Podcasts
    Episode 425: Robert Glazer : Host Elle Russ chats with Robert Glazer, founder and CEO of the global performance marketing agency...
    Read more ...


  • COVID-19 Diary Week 5: We're Open, but Where Are All the Patients?

    1 month ago - By Medscape

    Hospitals and cancer centers are opening back up, but patients who have suffered the 'societal trauma' of COVID-19 are not coming in.
    Medscape Oncology
    Read more ...